PubMed

Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients.

Nakamuta M, Kotoh K, Enjoji M, Kajiwara E, Shimono J, Masumoto A, Maruyama T, Furusyo N, Nomura H, Sakai H, Takahashi K, Azuma K, Shimoda S, Tanabe Y, Hayashi J.

Comp Hepatol. 2007 May 1;6:3.PMID: 17470300 [PubMed]Related articlesFree article

Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.

Pellicelli AM, Barbaro G, Francavilla R, Romano M, Barbarini G, Mazzoni E, Mecenate F, Paffetti A, Barlattani A, Struglia C, Villani R, Nauri L, Nosotti L, Armignacco O, Ferri F, Camporiondo MP, Soccorsi F; Club Epatologi Ospedalieri (CLEO) Group.

Clin Ther. 2008 Feb;30(2):317-23.PMID: 18343270 [PubMed - indexed for MEDLINE]Related articles

The long-term effects of lamivudine treatment in patients with HBeAg-negative liver cirrhosis.

Kilic ZM, Kuran S, Akdogan M, Cicek B, Oguz D, Odemis B, Sasmaz N.

Adv Ther. 2008 Mar;25(3):190-200.PMID: 18385953 [PubMed - indexed for MEDLINE]Related articles

Tenofovir plus lamivudine as rescue therapy for adefovir-resistant chronic hepatitis B in hepatitis B e antigen-positive patients with liver cirrhosis.

Choe WH, Kwon SY, Kim BK, Ko SY, Yeon JE, Byun KS, Kim GH, Lee CH.

Liver Int. 2008 Jul;28(6):814-20.PMID: 18312291 [PubMed - indexed for MEDLINE]Related articles

Clinical outcomes of chronic hepatitis B patients with persistently detectable serum hepatitis B virus DNA during lamivudine therapy.

Kim JH, Yu SK, Seo YS, Yim HJ, Yeon JE, Park JJ, Kim JS, Bak YT, Lee CH, Byun KS.

J Gastroenterol Hepatol. 2007 Aug;22(8):1220-5. Epub 2007 May 27.PMID: 17532786 [PubMed - indexed for MEDLINE]Related articles

Body surface area is an independent factor contributing to the effects of lamivudine treatment.

Nakamuta M, Kotoh K, Tanabe Y, Kajiwara E, Shimono J, Masumoto A, Maruyama T, Furusyo N, Nomura H, Sakai H, Takahashi K, Azuma K, Shimoda S, Enjoji M, Hayashi J; Kyushu University Liver Disease Study Group.

Hepatol Res. 2005 Jan;31(1):13-17. Epub 2004 Dec 28.PMID: 15652465 [PubMed - as supplied by publisher]Related articles

Evaluation of the cost-effectiveness of entecavir versus lamivudine in hepatitis BeAg-positive chronic hepatitis B patients.

Yuan Y, Iloeje UH, Hay J, Saab S.

J Manag Care Pharm. 2008 Jan-Feb;14(1):21-33.PMID: 18240879 [PubMed - indexed for MEDLINE]Related articlesFree article

Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infection.

Shinkai N, Tanaka Y, Orito E, Ito K, Ohno T, Hirashima N, Hasegawa I, Sugauchi F, Ueda R, Mizokami M.

Hepatol Res. 2006 Dec;36(4):272-276. Epub 2006 Sep 12.PMID: 16971173 [PubMed - as supplied by publisher]Related articles

Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?

Sheldon J, Ramos B, Toro C, Ríos P, Martínez-Alarcón J, Bottecchia M, Romero M, Garcia-Samaniego J, Soriano V.

Antivir Ther. 2008;13(1):97-102.PMID: 18389903 [PubMed - indexed for MEDLINE]Related articles

Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.

Pan XP, Li LJ, Du WB, Li MW, Cao HC, Sheng JF.

J Viral Hepat. 2007 Nov;14(11):767-74.PMID: 17927612 [PubMed - indexed for MEDLINE]Related articles

Treatment of chronic hepatitis B virus infection - Dutch national guidelines.

Buster EH, van Erpecum KJ, Schalm SW, Zaaijer HL, Brouwer JT, Gelderblom HC, de Knegt RJ, Minke Bakker C, Reesink HW, Janssen HL; Netherlands Association of Gastroenterologists and Hepatologists.

Neth J Med. 2008 Jul-Aug;66(7):292-306. Review.PMID: 18663260 [PubMed - indexed for MEDLINE]Related articlesFree article

Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment.

Kobayashi M, Suzuki F, Akuta N, Yatsuji H, Hosaka T, Sezaki H, Kobayashi M, Kawamura Y, Suzuki Y, Arase Y, Ikeda K, Mineta R, Iwasaki S, Watahiki S, Kumada H.

Hepatol Res. 2009 Sep 25. [Epub ahead of print]PMID: 19788696 [PubMed - as supplied by publisher]Related articles

[Predictors of lamivudine resistance in patients with chronic hepatitis B virus infection]

Heo J, Cho M, Cho BM, Lee SM, Kim TO, Kim GH, Kang DH, Song GA.

Korean J Hepatol. 2007 Jun;13(2):157-65. Korean. PMID: 17585189 [PubMed - indexed for MEDLINE]Related articlesFree article

[Change of HBV DNA level as a predictor of HBeAg loss after lamivudine treatment]

Jung JK, Lee CH, Kim EY, Jung JT, Choi JH, Han JM, Jin MI, Cho JY, Kim BS, Shin IH.

Korean J Hepatol. 2007 Dec;13(4):513-20. Korean. PMID: 18159149 [PubMed - indexed for MEDLINE]Related articlesFree article

[Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine-resistant chronic hepatitis B patients]

Cho JH, Cheong JY, Kang JK, Park JS, Lee MH, Lim NK, Hong SP, Kim SO, Yoo WD, Cho SW.

Korean J Hepatol. 2008 Mar;14(1):58-66. Korean. PMID: 18367858 [PubMed - indexed for MEDLINE]Related articlesFree article

Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir.

Matthews GV, Cooper DA, Dore GJ.

Antivir Ther. 2007;12(1):119-22.PMID: 17503756 [PubMed - indexed for MEDLINE]Related articles

Management of chronic hepatitis B.

Wilt TJ, Shamliyan T, Shaukat A, Taylor BC, MacDonald R, Yuan JM, Johnson JR, Tacklind J, Rutks I, Kane RL.

Evid Rep Technol Assess (Full Rep). 2008 Oct;(174):1-671. Review.PMID: 19408969 [PubMed - indexed for MEDLINE]Related articles

Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation.

Dai CY, Yu ML, Hsieh MY, Lee LP, Hou NJ, Huang JF, Chen SC, Lin ZY, Hsieh MY, Wang LY, Tsai JF, Chang WY, Chuang WL.

Liver Int. 2007 Dec;27(10):1364-70. Epub 2007 Sep 26.PMID: 17900250 [PubMed - indexed for MEDLINE]Related articles

[The follow-up of serum aminotransferase levels and investigation of hepatitis B virus load in inactive HBsAg carriers]

Olut AI, Ozünlü H, Bozdağ H, Ozkalay N.

Mikrobiyol Bul. 2007 Jul;41(3):429-33. Turkish. PMID: 17933254 [PubMed - indexed for MEDLINE]Related articles

Efficacy of lamivudine on hepatitis B viral status and liver function in patients with hepatitis B virus-related hepatocellular carcinoma.

Kim JH, Park JW, Koh DW, Lee WJ, Kim CM.

Liver Int. 2009 Feb;29(2):203-7. Epub 2008 Jul 24.PMID: 18662281 [PubMed - indexed for MEDLINE]Related articles